Clinical Trials Browser

Phase 2 × Carcinoma, Renal Cell × ixabepilone × Clear all

NCT00923130 2018-04-17

Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer

Phase 2 Completed

30 enrolled 12 charts

Carcinoma, Renal Cell

NCT00182702 2013-03-25

Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell

NCT00030992 2012-08-20

BMS 247550 to Treat Kidney Cancer

Phase 2 Completed

102 enrolled 10 charts

Carcinoma, Renal Cell, Kidney Neoplasms